Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
NCT00830115
·
clinicaltrials.gov ↗
COMPLETED
Status
1045
Enrollment
INDUSTRY
Sponsor class
Conditions
Sleep Disorders
Non-Erosive Reflux Disease
Gastroesophageal Reflux Disease
Interventions
DRUG:
Pantoprazole
Sponsor
Nycomed